Key Takeaways

• One of the central decisions in a California practice sale is asset sale vs. stock sale. Stock sales generally favor the seller (better capital gains treatment, cleaner exit, liabilities transfer to the buyer). Asset sales generally favor the buyer (limited liability exposure, better tax deductions). Most California physician practice sales end up as asset sales — and the seller’s tax treatment depends heavily on entity type.
• Pre-sale preparation matters more than negotiation. A practice that has been positioned for sale 2-3 years before the sale typically trades at a meaningfully higher multiple than one that’s hastily packaged. Financial cleanup, operational hygiene, and compliance documentation drive the multiple.
• Buyer types vary widely: physician successors, medical groups, hospital systems, private equity platforms, strategic operators. Each has different deal structures, valuation methodologies, post-closing employment expectations, and pricing dynamics.
• The § 16601 sale-of-business non-compete is the rare post-2024 non-compete that still works in California — and it’s most valuable in practice sales. Properly structured, it protects the buyer’s goodwill purchase. Improperly structured, it falls apart and the seller may face § 16600 enforcement exposure even where the seller is the one supposed to be restrained.
• Sellers have OHCA notice obligations too. AB 1415’s 90-day window applies to sellers of healthcare entities (and to MSOs being sold). Closing inside the 90 days isn’t an option for covered transactions.

Selling Your California Healthcare Practice

If you’re a California physician, dentist, chiropractor, optometrist, podiatrist, or other healthcare practitioner thinking about selling your practice — whether to a colleague, a medical group, a hospital system, or a private equity-backed platform — this post walks through the seller-side decisions that shape the deal.

This is the seller-side companion to our acquisition post. The acquisition post covers the deal from the buyer’s perspective; this one covers the same transactions from yours.

If you’re 6-36 months out from selling a California healthcare practice, the right time to start preparing is now. The financial, operational, and compliance positioning a seller does in advance directly drives the price the seller realizes at closing. Bay Legal, PC counsels California healthcare practice owners through pre-sale preparation, buyer selection, deal structure, definitive agreements, and closing across asset sale, stock sale, and merger transactions. Call (650) 668-8000 or schedule a consultation at baylegal.com/contact.

Why Asset Sale vs. Stock Sale Matters So Much for Sellers

One of the most important tax variables in a California practice sale is whether the transaction is structured as an asset sale or a stock sale.

Stock sale: seller’s preferred default

In a stock sale, the seller sells the shares of the corporation. The corporation continues as a going concern under new ownership.

• Capital gains treatment: The seller pays long-term capital gains tax on the difference between the sale price and the seller’s basis in the shares. Federal long-term capital gains rates are tiered (0%, 15%, and 20% as of drafting, with an additional Net Investment Income Tax for high earners). California has no separate capital gains rate; gains are taxed as ordinary income at California’s marginal rates. Federal and California rate brackets change with legislation and inflation adjustments; a CPA can confirm the rates and brackets that apply to the seller’s specific situation.
• One layer of tax: The seller pays once. No corporate-level tax.
• Liabilities transfer: All corporate liabilities — known and unknown — pass to the buyer with the shares. This is generally favorable to the seller (clean exit) and unfavorable to the buyer.

The CPOM constraint typically makes stock sales of California medical corporations available only to qualified licensed physician buyers. A PE-backed acquisition of a California medical corporation generally restructures into asset purchase + friendly-PC + MSO.

Asset sale: more common in practice

In an asset sale, the buyer purchases specific assets — equipment, patient records (where transferable), accounts receivable (sometimes), goodwill, certain contracts. The seller retains the corporate shell.

• Tax treatment for S-corp / partnership / LLC sellers: Pass-through entities avoid double taxation. The asset sale is taxed once at the shareholder/member level. Different asset categories receive different tax treatment:
  • Tangible assets (equipment, furniture): Ordinary income to the extent of depreciation recapture; capital gains for the balance.
  • Goodwill: Capital gains (the most favorable category).
  • Restrictive covenants (non-competes): Ordinary income to the seller.
  • Accounts receivable: Ordinary income.
• Tax treatment for C-corp sellers: Double taxation. The C-corp pays corporate-level tax on the asset sale gain; the shareholder then pays individual-level tax on the liquidating distribution. The effective combined rate can exceed 50%. This is why C-corp sellers strongly prefer stock sales and resist asset sales.
• Liabilities don’t transfer (mostly): The seller retains the corporate shell with historical liabilities. Tail insurance becomes critical to cover post-closing malpractice exposure.

Purchase price allocation

In an asset sale, the parties allocate the purchase price across asset categories. The allocation is bilateral — buyer and seller agree on it, and both report consistently to the IRS on Form 8594. Different allocations produce different tax outcomes:

• Buyer wants higher allocation to depreciable assets (faster deductions).
• Seller wants higher allocation to goodwill and capital-gain assets (lower tax rates).
• Restrictive covenant allocations convert capital gains income to ordinary income for the seller; sellers typically minimize this allocation.

Negotiating the allocation is part of the deal. A well-prepared seller has worked through the allocation with their CPA before the LOI is signed.

Pre-Sale Preparation: What Drives the Multiple

Most California physician practices that sell at premium multiples have been positioned for sale 24-36 months in advance. The positioning work isn’t glamorous; it’s bookkeeping, operational hygiene, and compliance documentation. The buyer’s due diligence team reads the same things, and what they find drives the price.

Financial cleanup

• Clean books for 3+ years. GAAP-consistent treatment, consistent revenue recognition, normalized owner compensation (most sellers run personal expenses through the practice; the buyer’s diligence will “add back” these expenses to show the true cash flow, but only if they’re identifiable).
• Documented “add-backs.” Owner perks, family employee compensation above market, personal vehicle expenses, conference and CME costs beyond standard, club memberships. The seller’s value increases when these are clearly identifiable as one-time or non-business.
• Audited or reviewed financials. Smaller practices often use compiled statements; reviewed or audited statements meaningfully strengthen the seller’s position with sophisticated buyers.
• Quality of earnings (QoE) report. Sell-side QoE prepared by the seller’s advisors gives the seller control of the narrative and surfaces issues early.

Operational hygiene

• Provider productivity documented (RVUs, encounters, panel size) — buyers value practices with multiple productive providers more than solo-physician practices.
• Patient base stability documented — retention rates, demographic stability, geographic distribution.
• Payor mix optimization — heavy concentration in one payor (especially a low-paying one) reduces the multiple; balanced commercial / Medicare / Medi-Cal / cash mix typically helps.
• Active patient count — buyers care about active patients (seen in the last 18-24 months), not total patient records.
• Operating systems — current EHR, working billing systems, documented workflows, current credentialing.

Compliance documentation

• CPOM compliance for any existing MSO arrangement — clean medical director documentation, current FMV analysis, post-SB 351 MSA terms.
• Standardized procedures for any RN-delegated or NP-delegated medical-practice functions.
• Patient records in good order — buyers will sample.
• Billing compliance — coding accuracy, modifier use, documentation supporting E/M levels.
• Stark and AKS review for federal-payor revenue practices.
• Employee classification — clean records on 1099 vs. W-2 status for clinicians and non-clinicians.
• SB 525 healthcare minimum wage compliance for current wage rates and historical periods.

Insurance

• Tail (extended reporting) coverage quotes — the buyer typically requires the seller to obtain tail coverage covering malpractice claims for the seller’s pre-closing acts, reported after closing.
• D&O run-off coverage for the seller’s officers and directors.
• Cyber coverage continuing through the transition.

Buyer Types and What Each Wants

Different buyer types have different valuation methodologies, deal structures, post-closing expectations, and price ranges. Knowing the buyer type before approaching the market shapes how the seller positions.

Physician successors (colleagues, employed associates, partnership track)

• Often the highest-trust, lowest-friction transactions.
• Pricing typically based on tangible assets + a modest goodwill multiple.
• Often financed by the buyer with seller-financing or SBA loans.
• Post-closing transition often involves the seller continuing in a reduced role for 6-24 months.
• CPOM-compliant by default; no structural issues.

Medical groups

• Acquire to expand geographic footprint, add specialty depth, capture referral flow.
• Typically higher multiples than individual successors.
• Often want the seller to continue as employee or contractor post-closing for 1-3 years.
• May want non-compete (subject to § 16601 sale-of-business carve-out).
• Stock purchases possible if buyer’s structure permits.

Hospital systems

• Acquire to control referral patterns, capture downstream services, expand network coverage.
• Pricing can be high but is constrained by Stark Law and AKS FMV requirements — hospital systems with federal payor exposure cannot pay above-FMV for practices that refer to them.
• Typically asset purchase + employment of the seller-physician post-closing.
• Significant integration work post-closing (EHR, billing, branding).
• Often expect 3-5 year employment commitments post-closing.

Private equity / PE-backed MSO platforms

• Acquire physician practices as part of multi-state or regional roll-ups.
• Higher multiples than other buyer types in many specialties (dermatology, ophthalmology, dental, GI, anesthesia, orthopedics, women’s health).
• Always structured as asset purchase + friendly-PC + MSO (due to CPOM).
• Typically expect the seller to roll equity into the MSO platform — partial cash, partial equity in the platform — for tax efficiency and continued upside.
• Subject to SB 351 contract restrictions (non-compete and non-disparagement provisions voided outside the sale-of-business carve-out).
• Subject to AB 1415 90-day OHCA notice obligation.

Strategic operators (non-PE healthcare companies)

• Acquire for vertical integration, technology deployment, or market expansion.
• Pricing varies; can be premium for specialty practices that fit a strategic need.
• Deal structures vary; often asset purchases + post-closing earnout arrangements.

The pre-sale preparation work that drives valuation outcomes typically starts 18-36 months before the seller wants to close. Bay Legal, PC counsels California healthcare practice owners through pre-sale positioning, buyer-side targeting, LOI negotiation, definitive document drafting, and closing — including the federal and state regulatory steps the seller has to handle. Call (650) 668-8000 or schedule a consultation at baylegal.com/contact.

The § 16601 Sale-of-Business Non-Compete (and Why It Matters for Sellers)

For most California employment relationships, non-competes are void under B&P § 16600 as amended by AB 1076 and SB 699 in 2024. The narrow exception that survives — and that’s central to practice sales — is B&P § 16601, the sale-of-business non-compete.

Section 16601 permits a non-compete clause when:

• The seller is selling either all of their ownership interest in a business or the goodwill of the business.
• The buyer intends to carry on a like business in the geographic area.
• The non-compete is limited to the geographic area in which the business operates.
• The non-compete is reasonable in duration.

For a California practice sale, the § 16601 non-compete is the buyer’s primary protection for the goodwill purchased. Without it, the buyer pays for goodwill that the seller can re-create by opening a new practice across the street. With it, the seller is restricted from competing within the geographic and temporal scope of the goodwill sale.

For sellers, the § 16601 analysis matters in two directions:

• The seller’s exposure to a sale-of-business non-compete: A properly structured § 16601 clause is enforceable. A non-compete in an asset-purchase agreement is generally upheld; a separate post-closing employment-agreement non-compete tied to the employment relationship (rather than to the sale) is typically not (Fillpoint v. Maas makes this point).
• The price reflects the protection: Buyers pay more for goodwill they can protect. A seller who refuses to grant a reasonable § 16601 non-compete typically receives a lower price.

Structuring a defensible § 16601 non-compete

• Tied to the sale, not to employment. The non-compete sits in the asset-purchase or stock-purchase agreement, not in a separate post-closing employment agreement.
• Geographic scope matches the practice’s actual service area (not the entire state, not a national area).
• Duration reasonable in light of the goodwill being transferred — 3-5 years is common; 7+ years can be defended in larger transactions but starts to attract scrutiny.
• Specific industry definition — limiting the seller from competing in the specific specialty and clinical service line being sold, rather than from any healthcare-related activity.
• Real goodwill payment — the purchase price has to actually reflect goodwill being transferred. A nominal allocation to goodwill won’t support an aggressive non-compete.

For PE/hedge fund-backed buyers of physician or dental practices, SB 351 (effective January 1, 2026) preserves the § 16601 sale-of-business non-compete carve-out — bona fide sale-of-business non-competes permitted under California law remain valid. The non-compete language has to be carefully drafted to fit the carve-out; the broader employment-style non-compete that PE-backed MSAs often included is voided.

OHCA Notice for Sellers

The 90-day OHCA notice obligation under AB 1415 isn’t only the buyer’s problem. The statute applies to “noticing entities” on both sides of a material change transaction. Sellers in larger transactions:

• May have direct notice obligations as healthcare entities themselves.
• Need to confirm the buyer’s notice timeline (a buyer that misses the 90-day window can delay or unwind the seller’s closing).
• May need to coordinate disclosure timing with their own confidentiality obligations.

The 90-day window also affects competitive dynamics: a seller in an auction process needs to confirm that all serious bidders can accommodate the timing. A bidder with a roll-up strategy involving multiple California healthcare entities may face longer OHCA review than a single-transaction bidder.

Patient Records and Patient Notification

California has specific rules on patient records during practice sales:

• Patient records ownership: Patient records belong to the patient, with the practice acting as custodian. The records transfer in a practice sale subject to specific patient notification and consent rules.
• Patient notification: Patients must be notified of the sale and of the new custodian. The notification typically includes the option for the patient to request transfer of their records to another provider rather than to the buyer.
• Record retention: California sets minimum patient-record retention periods that vary by record type, practitioner license, and patient age. A typical baseline for adult medical records is several years from the date of last service, and for records made during patient minority, retention generally runs into adulthood. The applicable licensing board (Medical Board, Dental Board, BCE, etc.) publishes the current rules; consult the board’s published guidance and allocate retention responsibility expressly between seller and buyer in the definitive agreement.
• HIPAA Business Associate Agreement: Required if a third party (e.g., a record storage vendor) will have access to records during or after the transition.

Post-Closing Employment, Earnouts, and Rollover Equity

The seller’s relationship with the practice typically doesn’t end at closing. Common post-closing arrangements:

Employment or independent contractor agreement

• Seller continues to practice for 6 months to 5 years post-closing.
• Compensation usually below the seller’s prior owner compensation (the buyer is now capturing the owner profit).
• Subject to AB 5 / Borello analysis if structured as 1099 — physician sellers have the § 2783(b) exemption; non-physician sellers (NPs, PAs, chiropractors, etc.) generally don’t.

Earnouts

• A portion of the purchase price tied to post-closing performance — typically EBITDA, revenue, patient retention, or specific performance metrics.
• Common in deals with valuation uncertainty.
• Subject to Stark Law and AKS scrutiny if federal-payor revenue is involved (the post-closing payment can’t be structured in a way that takes referral volume into account).
• Negotiate the formula and the dispute resolution mechanism carefully — buyer-controlled metrics give the buyer too much leverage.

Rollover equity

• Standard in PE-backed acquisitions. The seller takes part of the consideration in equity of the acquirer or its parent.
• Tax-deferred treatment (Section 351 or partnership rollover) preserves the seller’s basis until the rollover equity is monetized at the second sale.
• Provides the seller continued upside if the platform succeeds.
• Comes with PE-platform restrictions (drag-along, tag-along, transfer restrictions, repurchase rights).

Common Pitfalls for Sellers

1. No pre-sale preparation. The seller approaches the market without financial cleanup or operational hygiene; price comes in below expectation.
2. C-corp tax structure in place at the sale — double taxation reduces the seller’s net proceeds substantially.
3. No tail insurance arranged before closing — the seller is exposed to malpractice claims arising from pre-closing services with no coverage.
4. Patient notification mishandled, creating regulatory exposure for both seller and buyer.
5. Sale-of-business non-compete drafted in a way that won’t survive § 16601 / SB 351 scrutiny.
6. Earnout formula poorly drafted — buyer controls the metrics; seller never realizes the earnout.
7. Rollover equity terms accepted without negotiation — drag-along rights and repurchase rights can leave the seller unable to monetize.
8. Stark Law / AKS issues in the seller’s referral patterns that surface in diligence and reduce the price (or kill the deal).
9. Sub-par advisory team — sellers who use generalist transaction counsel often miss healthcare-specific issues that materially affect the deal economics.
10. Failure to plan around the OHCA 90-day window — the seller’s closing timing collapses.

Talk to a California Healthcare Practice Sale Attorney

Selling a California healthcare practice is typically the largest financial transaction in a physician’s, dentist’s, or other practitioner’s career. The work that drives the outcome — pre-sale positioning, buyer selection, deal structure, definitive document negotiation, post-closing transition — is healthcare-specific and California-specific. The cost of getting it right is small relative to the difference in net proceeds between a well-prepared sale and a hastily executed one.

If you’re considering selling a California healthcare practice — solo, multi-physician, MSO-backed, or part of a larger transaction — attorneys at Bay Legal, PC counsel sellers through pre-sale preparation, buyer targeting, LOI negotiation, definitive agreement drafting and negotiation, tax structuring with CPA coordination, OHCA notice, SB 351 compliance, and closing across the full range of California healthcare transactions. Call (650) 668-8000 or schedule a consultation at baylegal.com/contact.

Frequently Asked Questions

Is a stock sale or an asset sale better for a California healthcare practice seller?

In most cases, a stock sale is better for the seller. Stock sales offer cleaner capital gains tax treatment (no double taxation), pass corporate liabilities to the buyer (clean exit), and avoid the asset-by-asset allocation negotiation. Asset sales are better for buyers and are more common in practice because California’s CPOM doctrine often makes stock sales unavailable to non-physician buyers. For C-corp sellers, asset sales create double taxation; the C-corp-to-S-corp conversion (with the 5-year built-in gains period) is worth considering well before a sale to address this issue.

How far in advance should I start preparing to sell my California medical practice?

24-36 months in advance for the highest realization. The work that drives the multiple — clean financials, normalized owner compensation, documented operational metrics, compliance documentation, payor mix optimization — takes time to put in place. Sellers who start preparation 6 months before approaching the market typically realize lower prices because buyers can see the unprepared state in due diligence. Sellers with 2-3 years of clean preparation realize meaningfully better outcomes.

Will I be able to sign a non-compete when I sell my California practice?

Yes, but only the § 16601 sale-of-business non-compete remains enforceable in 2026. The clause has to be tied to the sale of the business (not to a separate post-closing employment relationship), reasonable in geographic and temporal scope, and supported by real goodwill being transferred. The 2024 amendments to § 16600 (AB 1076 and SB 699) made employment non-competes generally unenforceable, but the § 16601 carve-out for practice sales survives. For PE/hedge fund-backed buyers, SB 351 (effective 2026) preserves the § 16601 carve-out specifically.

Does the OHCA 90-day notice apply to me as a seller?

In larger transactions, yes. AB 1415 (effective January 1, 2026) applies the 90-day notice obligation to “noticing entities” on both sides of a material change transaction involving healthcare entities or MSOs. The buyer often takes the lead on filing, but sellers need to confirm the buyer’s timeline (a buyer that misses the window can delay or unwind closing) and may have independent notice obligations as healthcare entities themselves. The materiality thresholds are defined in OHCA’s implementing regulations.

What about rollover equity in a PE-backed sale?

Rollover equity is standard in PE-backed California healthcare practice acquisitions. The seller takes part of the purchase price as equity in the buyer’s MSO platform or its parent entity, typically with tax-deferred treatment under IRC § 351 (for corporate structures) or partnership rollover provisions. The rollover provides the seller continued upside if the platform succeeds, and the deferred tax treatment can be substantial. Negotiate carefully on the rollover terms — drag-along rights, tag-along rights, repurchase rights, valuation mechanics, and exit timing all materially affect the value of the rollover.

This article provides general information about California law and is not legal, tax, or financial advice. Reading this article, contacting Bay Legal, PC, or sending information through baylegal.com does not create an attorney-client relationship. The information here focuses on California law and may not reflect the law of other jurisdictions. Statutes, regulations, agency guidance, and case law change; this article reflects the authors’ understanding as of the date of publication and may not reflect later developments. For advice about your specific situation, consult a licensed California attorney and, for tax questions, a CPA.